CNS Pharmaceuticals appoints Faith L. Charles as Chair of the Board of Directors
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
To create leading company developing medicines targeting metalloenzymes
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
The company is one of the most profitable companies manufacturing speciality chemicals in India
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Subscribe To Our Newsletter & Stay Updated